Psychiatry Care Live

CME Presentations

Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect


Presentations

  • CME
    1.0

    Part 1 - Mechanisms and Management of Agitation in Alzheimer's Disease

    Speakers:David Beck, MD, Associate Professor, Department of Psychiatry and Behavioral Neuroscience
    George T. Grossberg, MD, Samuel W. Fordyce Professor; Director, Geriatric Psychiatry

    Duration: 60 minutes

    Presented on: April 4, 2017

  • CME
    1.0

    Part 2 - Challenges in Managing Treatment-Resistant Depression

    Speakers:Charles B. Nemeroff, MD, PhD, Leonard M. Miller Professor and Chairman, Department of Psychiatry and Behavioral Sciences
    Michael E. Thase, MD, Professor of Psychiatry

    Duration: 60 minutes

    Presented on: June 23, 2017


Speakers

  • David Beck, MD

    David Beck, MD

    David Beck, MD

    Associate Professor, Department of Psychiatry and Behavioral Neuroscience

    David Beck, MD, is currently an associate professor in the Department of Psychiatry and Behavioral Neuroscience, in the Division of Geriatric Psychiatry, at Saint Louis University School of Medicine in Missouri. Dr Beck’s interests include caring for patients with dementia, anxiety and depression in the elderly, telepsychiatry, and palliative care. He is a member of the American Association for Geriatric Psychiatry and has more than 20 years’ experience in providing psychiatric consultation to nursing homes. He is a graduate of The University of Iowa College of Medicine, where he completed a residency in internal medicine and psychiatry, and completed additional training in geriatric medicine at Duke University.
  • George T. Grossberg, MD

    George T. Grossberg, MD

    George T. Grossberg, MD

    Samuel W. Fordyce Professor; Director, Geriatric Psychiatry

    George T. Grossberg, MD, is the Samuel W. Fordyce Professor in the Departments of Neurology & Psychiatry, Anatomy and Neurobiology and Internal Medicine, and director, Division of Geriatric Psychiatry, at the Saint Louis University School of Medicine in Missouri. He consults in the development of protocols for central nervous system disorders in older patients, and he is involved in a variety of basic as well as clinical research projects in the area of dementing disorders, with a focus on behavioral disturbances in dementia. Dr Grossberg is a diplomat of the National Board of Medical Examiners, a distinguished fellow of the American Psychiatric Association, and holds membership in numerous professional societies. He completed his MD at the Saint Louis University School of Medicine.
  • Charles B. Nemeroff, MD, PhD

    Charles B. Nemeroff, MD, PhD

    Charles B. Nemeroff, MD, PhD

    Leonard M. Miller Professor and Chairman, Department of Psychiatry and Behavioral Sciences

    Charles B. Nemeroff, MD, PhD, is the Leonard M. Miller Professor and Chairman of the Department of Psychiatry and Behavioral Sciences, and clinical director of the Center on Aging at the University of Miami Miller School of Medicine in Florida. He chairs the American Psychiatric Association (APA) Research Colloquium for Young Investigators and the APA Work Group on Biomarkers and Novel Treatments. He is past president of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP), and is on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America (ADAA). He earned his MD and PhD from the UNC School of Medicine in Chapel Hill, North Carolina.
  • Michael E. Thase, MD

    Michael E. Thase, MD

    Michael E. Thase, MD

    Professor of Psychiatry

    Michael E. Thase, MD, is professor of psychiatry and director of the Mood and Anxiety Section in the department of psychiatry at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and directs the Mood Disorders Research studies at the Philadelphia Veterans Affairs Medical Center. Dr Thase’s research focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder. He has authored or co-authored 16 books, numerous scientific articles and book chapters, and is involved in several professional organizations that include the American Psychiatric Association, the American Society of Clinical Psychopharmacology, and the National Depression and Bipolar Support Alliance.

CME Information

Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect Part I MECHANISMS AND MANAGEMENT OF AGITATION IN ALZHEIMER'S DISEASE

Presented by the Albert Einstein College of Medicine and Montefiore Medical Center in Joint Providership with PlatformQ Health Education, LLC

 

ACKNOWLEDGEMENT This educational activity is supported by an educational grant from Avanir Pharmaceuticals, Inc.

TUITION Complimentary

ACCREDITATION STATEMENT The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Internet Activity Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Enduring Material Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program

DATE OF RELEASE/EXPIRATION Live Activity Tuesday, April 4, 2017, from 1:00 PM EST – 2:00 PM EST Enduring Material The enduring material will be available from April 4, 2017 to June 23, 2018.

LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:

Identify different and various forms of agitation among patients with Alzheimer's disease (AD).
Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD
 

INTENDED AUDIENCE US-based neurologists, psychiatrists, geriatricians, primary care clinicians (internal, general and family medicine), and health care providers involved in the care of patients with neuropsychiatric sequelae who may be suffering from agitation as a result of Alzheimer's disease (AD).

ESTIMATED TIME TO COMPLETE This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenters Disclosures
George T. Grossberg, MD

Consulting Fee: Acadia; Allergan; Avanir; Axovant; Lundbeck; Novartis; Otsuka; Takeda Speaker's Bureau: Acadia Contracted Research: Cognoptix; Janssen

David Beck, MD

Dr. Beck has nothing to disclose relevant to this activity

 

Peer Reviewer Disclosures
David M. Kaufman, MD Has nothing to disclose relevant to this activity.
Providers Disclsoures
Einstein-Montefiore Center for Continuing Medical Education The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.
 

PlatformQ Health Education, LLC Disclsoures
Anne Roc, PhD, Medical Director Has nothing to disclose relevant to this activity
Karen Greb–Murphy, Program Manager Has nothing to disclose relevant to this activity.
 

CONTACT INFORMATION Accreditation Support: Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

Technical Support: For issues with your CME Certificate, please contact NeuroSeriesLive or PsychiatryCareLive at 877–394–1306 or at Support@NeuroSeriesLive.com or Support@PsychiatryCareLive.com

DISCLAIMERS (if applicable): The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, NeuroSeriesLive, PsychiatryCareLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.